Clinical Trial Update: Predictive Value of NT-proBNP on MACEs After Acute Coronary Syndrome

View source ↗

Summary

A completed clinical study evaluating whether NT-proBNP levels predict major adverse cardiac events after acute coronary syndrome, including STEMI and NSTEMI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Acute Coronary Syndrome, ST-segment Elevation Myocardial Infarction (STEMI) | Status: COMPLETED